0001127602-23-030181.txt : 20231220 0001127602-23-030181.hdr.sgml : 20231220 20231220163545 ACCESSION NUMBER: 0001127602-23-030181 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doyle Anthony CENTRAL INDEX KEY: 0001808688 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 231501738 MAIL ADDRESS: STREET 1: 4505 EMPEROR BLVD. STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-12-19 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001808688 Doyle Anthony 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Chief Financial Officer 0 Common Stock 2023-12-19 4 F 0 2482 6.05 D 227444 D Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person. /s/ Alane P. Barnes, by power of attorney 2023-12-20